These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 34753059)

  • 1. Design, parallel synthesis of Biginelli 1,4-dihydropyrimidines using PTSA as a catalyst, evaluation of anticancer activity and structure activity relationships via 3D QSAR studies.
    Faizan S; Prashantha Kumar BR; Lalitha Naishima N; Ashok T; Justin A; Vijay Kumar M; Bistuvalli Chandrashekarappa R; Manjunathaiah Raghavendra N; Kabadi P; Adhikary L
    Bioorg Chem; 2021 Dec; 117():105462. PubMed ID: 34753059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel Biginelli dihydropyrimidines with potential anticancer activity: a parallel synthesis and CoMSIA study.
    Prashantha Kumar BR; Sankar G; Nasir Baig RB; Chandrashekaran S
    Eur J Med Chem; 2009 Oct; 44(10):4192-8. PubMed ID: 19525040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel dihydropyrimidines as promising EGFR & HER2 inhibitors: Insights from experimental and computational studies.
    Faizan S; Wali AF; Talath S; Rehman MU; Sivamani Y; Nilugal KC; Shivangere NB; Attia SM; Nadeem A; Elayaperumal S; Kumar BRP
    Eur J Med Chem; 2024 Sep; 275():116607. PubMed ID: 38908102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thieno[2,3-d]pyrimidin-4(3H)-one Derivatives of Benzimidazole as Potential Anti- Breast Cancer (MDA-MB-231, MCF-7) Agents.
    Dimov S; Mavrova AT; Yancheva D; Nikolova B; Tsoneva I
    Anticancer Agents Med Chem; 2021; 21(11):1441-1450. PubMed ID: 32698751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, in vitro biological activities and in silico study of dihydropyrimidines derivatives.
    Barakat A; Islam MS; Al-Majid AM; Ghabbour HA; Fun HK; Javed K; Imad R; Yousuf S; Choudhary MI; Wadood A
    Bioorg Med Chem; 2015 Oct; 23(20):6740-8. PubMed ID: 26381063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Remarkable anti-breast cancer activity of ferrocene tagged multi-functionalized 1,4-dihydropyrimidines.
    Jadhav J; Juvekar A; Kurane R; Khanapure S; Salunkhe R; Rashinkar G
    Eur J Med Chem; 2013 Jul; 65():232-9. PubMed ID: 23711834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis, and molecular docking study of new monastrol analogues as kinesin spindle protein inhibitors.
    El-Hamamsy MH; Sharafeldin NA; El-Moselhy TF; Tawfik HO
    Arch Pharm (Weinheim); 2020 Aug; 353(8):e2000060. PubMed ID: 32452567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and in vitro anticancer and antitubercular activity of diarylpyrazole ligated dihydropyrimidines possessing lipophilic carbamoyl group.
    Yadlapalli RK; Chourasia OP; Vemuri K; Sritharan M; Perali RS
    Bioorg Med Chem Lett; 2012 Apr; 22(8):2708-11. PubMed ID: 22437116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel Pyrazolo[3,4-d]pyrimidines as Potential Cytotoxic Agents: Design, Synthesis, Molecular Docking and CDK2 Inhibition.
    Maher M; Kassab AE; Zaher AF; Mahmoud Z
    Anticancer Agents Med Chem; 2019; 19(11):1368-1381. PubMed ID: 31038080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and biological validation of novel pyrazole derivatives with anticancer activity guided by 3D-QSAR analysis.
    Vujasinović I; Paravić-Radičević A; Mlinarić-Majerski K; Brajša K; Bertoša B
    Bioorg Med Chem; 2012 Mar; 20(6):2101-10. PubMed ID: 22341245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, Synthesis, and Biological Evaluation of Substituted Pyrimidines as Potential Phosphatidylinositol 3-Kinase (PI3K) Inhibitors.
    Zhang JQ; Luo YJ; Xiong YS; Yu Y; Tu ZC; Long ZJ; Lai XJ; Chen HX; Luo Y; Weng J; Lu G
    J Med Chem; 2016 Aug; 59(15):7268-74. PubMed ID: 27427973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis, and computational studies on dihydropyrimidine scaffolds as potential lipoxygenase inhibitors and cancer chemopreventive agents.
    Venugopala KN; Govender R; Khedr MA; Venugopala R; Aldhubiab BE; Harsha S; Odhav B
    Drug Des Devel Ther; 2015; 9():911-21. PubMed ID: 25733811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design and synthesis of thienopyrimidine urea derivatives with potential cytotoxic and pro-apoptotic activity against breast cancer cell line MCF-7.
    Abdelhaleem EF; Abdelhameid MK; Kassab AE; Kandeel MM
    Eur J Med Chem; 2018 Jan; 143():1807-1825. PubMed ID: 29133058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of novel thiazolyl-pyrimidines and their anticancer activity in vitro.
    Shi HB; Li HB; Lu KQ; Zhu XR; Hu WX; Pei W
    Arch Pharm (Weinheim); 2011 Oct; 344(10):675-83. PubMed ID: 21984017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis of novel hetero ring fused pyridine derivatives; Their anticancer activity, CoMFA and CoMSIA studies.
    Santhosh Kumar G; Poornachandra Y; Kumar Gunda S; Ratnakar Reddy K; Mohmed J; Shaik K; Ganesh Kumar C; Narsaiah B
    Bioorg Med Chem Lett; 2018 Jul; 28(13):2328-2337. PubMed ID: 29798826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New thieno[3,2-d]pyrimidine-based derivatives: Design, synthesis and biological evaluation as antiproliferative agents, EGFR and ARO inhibitors inducing apoptosis in breast cancer cells.
    Farghaly AM; AboulWafa OM; Baghdadi HH; Abd El Razik HA; Sedra SMY; Shamaa MM
    Bioorg Chem; 2021 Oct; 115():105208. PubMed ID: 34365057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and synthesis of novel 1,2,3-triazole-pyrimidine hybrids as potential anticancer agents.
    Ma LY; Pang LP; Wang B; Zhang M; Hu B; Xue DQ; Shao KP; Zhang BL; Liu Y; Zhang E; Liu HM
    Eur J Med Chem; 2014 Oct; 86():368-80. PubMed ID: 25180925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of Novel Rhodanine Analogs as Anticancer Agents: Design, Synthesis, Evaluation and CoMSIA Study.
    Krithika U; Prabitha P; Mandal SP; Yuvaraj S; Priya D; Wadhwani AD; Prashantha Kumar BR
    Med Chem; 2021; 17(3):216-229. PubMed ID: 32520692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural optimization, synthesis and in vitro synergistic anticancer activities of combinations of new N3-substituted dihydropyrimidine calcium channel blockers with cisplatin and etoposide.
    El-Wakil MH; Teleb M; Abu-Serie MM; Huang S; Zamponi GW; Fahmy H
    Bioorg Chem; 2021 Oct; 115():105262. PubMed ID: 34411980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis and anticancer activity of novel pyrimidine and pyrimidine-thiadiazole hybrid glycosides.
    Khalaf HS; Tolan HEM; Radwan MAA; Mohamed AM; Awad HM; El-Sayed WA
    Nucleosides Nucleotides Nucleic Acids; 2020; 39(7):1036-1056. PubMed ID: 32312171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.